« Competing (And Competing Unethically?) |
| Arena / Lorcaserin Update »
May 18, 2009
San Francisco Biotech: Holding Up, or Not?
I've got a piece coming up today at The Atlantic Monthly's business site on the state of the biotech industry out in the Bay Area. Since the Genentech takeover fight broke out, a persistent theme in the comments here (and in e-mail that I've received) has been how well the industry is holding up out there. Opinions range from "basically fine" (a minority, to be sure), to "incipient disaster" (also a minority, but a loud one). The consensus view is that there may well be room to worry.
So let's start the discussion explicitly (here as well as over at The Atlantic. How healthy is the original biotech cluster? And how many of its current problems are due to secular reasons (the general economy, the general state of the drug industry), and how many are home-grown? I'd be very interested to hear from people out there, although I guess it'll be mostly us Eastern types for the next few hours here. . .
+ TrackBacks (0) | Category: Business and Markets | Drug Industry History
POST A COMMENT
- RELATED ENTRIES
- How Not to Do It: NMR Magnets
- Allergan Escapes Valeant
- Vytorin Actually Works
- Fatalities at DuPont
- The New York TImes on Drug Discovery
- How Are Things at Princeton?
- Phage-Derived Catalysts
- Our Most Snorted-At Papers This Month. . .